Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 41Melanoma 8Uterine Cervical Neoplasms 7Endometrial Neoplasms 7Mouth Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 4Vulvar Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Uterine Neoplasms 2Rectal Neoplasms 2Neoplasm Micrometastasis 2Neoplasm Metastasis 2Lymphatic Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Head and Neck Neoplasms 2Eccrine Porocarcinoma 2Breast Neoplasms, Male 2Breast Carcinoma In Situ 2Waldenstrom Macroglobulinemia 1Sentinel Lymph Node Biopsy (SLNB) 1Sentinel Lymph Node 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Recurrence 1Recurent Vulvar Carcinoma 1Prostatic Neoplasms 1Penile Neoplasms 1Pediatric Patients With Solid Tumors 1Pancreatic Neoplasms 1

Interventions

Telemedicine 1Sentinel Lymph Node Biopsy 1Ovariectomy 1Interviews as Topic 1Hysterectomy 1Health Promotion 1Exercise Test 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Sentinel Lymph Node Biopsy × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡